Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 1.53 |   |
Earnings Per Share | -$1.41 |   |
Price To Sales Ratio | 4.44 |   |
Price To Book Ratio | 2.96 |   |
Price To Tangible Book Ratio | 3.03 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 115.1M |   |
Float (MRQ) | 93.80% |   |
Shares Outstanding (MRQ) | 65.4M |   |
Short Interest as a % of Float (MRQ) | 5.89% |   |
Shares Held By Institutions (MRQ) | 24.6M |   |
Margins | Industry Range | |
---|---|---|
Sales | $70.7M |   |
Gross Margin | 97.90% |   |
Net Profit Margin | -129.97% |   |
EBIT Margin | -130.23% |   |
EBITDA Margin | -121.98% |   |
Operating Margins | -130.23% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 2.92 |   |
Quick Ratio (MRQ) | 2.92 |   |
Total Debt/Equity Ratio (MRQ) | 30.51 |   |
Debt/Common Equity Ratio (MRQ) | 30.51 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -91.89% |   |
Return on Assets | -33.72% |   |
Asset Turnover | 0.26 |   |
Receivables Turnover | 78.08 |   |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 15.45% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*CTMX does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%